Medication Management Systems has been acquired by Genoa

July 2017 – Medication Management Systems, Inc. (“MMS”) was acquired by Genoa, a QoL Healthcare Company, (“Genoa”).  England Securities acted as exclusive financial advisor for MMS in this transaction.

MMS provides comprehensive, patient-centered medication management services and technology to improve medication therapy by identifying and resolving patients’ medication therapy problems. The specially-trained MMS pharmacists deliver pharmaceutical care to improve the health of patients, improve efficiency and profitability of care delivery for physicians, and generate cost reduction and quality improvement for payers. MMS offers population analytics and state of the art technology in the MMS Nexus Pharmaceutical Care System™, a hosted, fully-integrated, cloud-based platform designed to support the delivery of comprehensive medication management services and the administration of medication therapy management programs.

“When we started seeking growth capital, we knew that someday we would likely end up in a strategic combination with a larger company,” noted Dave McLean, PhD, Chairman/CEO of MMS. “It happened sooner than we thought as things are moving quickly in chronic care and several strategic parties expressed interest in MMS.  The England team was instrumental in our discussions with numerous corporate buyers and investors, and in getting this transaction to the finish line.”

Genoa has been serving the behavioral health community for more than 15 years. The company provides pharmacy and telepsychiatry services to more than 550,000 individuals annually in 48 states and the District of Columbia, filling more than 12 million prescriptions per year. Genoa is the sixth largest drug chain in the United States with nearly 370 pharmacies located onsite within community mental health centers.